SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 15.22 |
| Enterprise Value ($M) | -32.02 |
| Book Value ($M) | 35.05 |
| Book Value / Share | 0.85 |
| Price / Book | 0.43 |
| NCAV ($M) | 33.96 |
| NCAV / Share | 0.82 |
| Price / NCAV | 0.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.92 |
| Return on Assets (ROA) | -1.17 |
| Return on Equity (ROE) | -1.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.41 |
| Current Ratio | 3.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 48.04 |
| Assets | 49.12 |
| Liabilities | 14.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -70.06 |
| Net Income | -67.79 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -60.30 |
| Cash from Investing | 0.00 |
| Cash from Financing | 37.18 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Balyasny Asset Management Llc | 0.00 | -100.00 | |
| 13D/A | Beigene, Ltd. | 3.17 | -90.00 | |
| 13G | Samsara BioCapital, L.P. | 6.40 | ||
| 13G | Gilead Sciences Inc | 13.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 129,901 | 303,282 | 42.83 | |
| 65,221 | 176,313 | 36.99 | |
| 157,366 | 469,692 | 33.50 | |
| 135,388 | 364,100 | 37.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LIPO – Lipella Pharmaceuticals Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
| LPCN – Lipocine Inc. | LQDA – Liquidia Corporation |
| LSTA – Lisata Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io